Cited by 112

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Second Asian Consensus on Irritable Bowel Syndrome

Gwee, Kok Ann, Gonlachanvit, Sutep, Ghoshal, Uday C, Chua, Andrew S B, Miwa, Hiroto, Wu, Justin, Bak, Young-Tae, Lee, Oh Young, Lu, Ching-Liang, Park, Hyojin, Chen, Minhu, Syam, Ari F, Abraham, Philip, Sollano, Jose, Chang, Chi-Sen, Suzuki, Hidekazu, Fang, Xiucai, Fukudo, Shin, Choi, Myung-Gyu, Hou, Xiaohua, Hongo, Michio·2019·Journal of Neurogastroenterology and Motility

DOI 10.5056/jnm19041

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.5056/jnm19041

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Stool form scale as a useful guide to intestinal transit time
Lewis, S. J., & Heaton, K. W. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011203 · Cited by 3,244 · cited 2×
“It has consistently being shown that stool form rather than stool frequency better represent colonic transit time.(18,19) Therefore, evaluating stool form using the Bristol scale is suggested as the tool”
BackgroundMethod
Psychosomatic medicine in Germany: more timely than ever
Zipfel, S., Herzog, W., Kruse, J., & Henningsen, P. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447701 · Cited by 2,323
Rome IV—Functional GI Disorders: Disorders of Gut-Brain Interaction
Drossman, D. A., & Hasler, W. L. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.035 · Cited by 1,928
Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome
Spiller, R. C., Jenkins, D., Thornley, J. P., Hebden, J. M., Wright, T., Skinner, M., & Neal, K. R. (2000) · Gut · doi:10.1136/gut.47.6.804 · Cited by 1,155
Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
Pimentel, M., Lembo, A., Chey, W. D., Zakko, S., Ringel, Y., Yu, J., Mareya, S. M., Shaw, A. L., Bortey, E., & Forbes, W. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1004409 · Cited by 1,036
Activation of the mucosal immune system in irritable bowel syndrome
Chadwick, V. S., Chen, W., Shu, D., Paulus, B., Bethwaite, P., Tie, A., & Wilson, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.33579 · Cited by 833
Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis
Ford, A. C., Quigley, E. M. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Moayyedi, P. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.202 · Cited by 747 · cited 1×
“beneficial effect in IBS, but not all probiotics have demonstrated benefit.(180) Thus, which species or combination was the most beneficial is unclear.”
Background
Defecation frequency and timing, and stool form in the general population: a prospective study.
Heaton, K. W., Radvan, J., Cripps, H., Mountford, R. A., Braddon, F. E., & Hughes, A. O. (1992) · Gut · doi:10.1136/gut.33.6.818 · Cited by 733
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis
Ford, A. C., Talley, N. J., Schoenfeld, P. S., Quigley, E. M. M., & Moayyedi, P. (2009) · Gut · doi:10.1136/gut.2008.163162 · Cited by 582
The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review
Sperber, A. D., Dumitrascu, D., Fukudo, S., Gerson, C., Ghoshal, U. C., Gwee, K. A., Hungin, A. P. S., Kang, J.-Y., Minhu, C., Schmulson, M., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-311240 · Cited by 554
Self-citation
Validity and reliability of the Bristol Stool Form Scale in healthy adults and patients with diarrhoea‐predominant irritable bowel syndrome
Blake, M. R., Raker, J. M., & Whelan, K. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13746 · Cited by 495
Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction.
Whitehead, W. E., Crowell, M. D., Robinson, J. C., Heller, B. R., & Schuster, M. M. (1992) · Gut · doi:10.1136/gut.33.6.825 · Cited by 432 · cited 1×
“symptoms in IBS patients show higher correlation than that in healthy individuals.(49) IBS patients show more exaggerated colonic motility in response to experimental stress than healthy subjects.”
Background
Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome
Gwee, K.-A. (2003) · Gut · doi:10.1136/gut.52.4.523 · Cited by 415
Self-citation
Quantitative Meta-analysis Identifies Brain Regions Activated During Rectal Distension in Irritable Bowel Syndrome
Tillisch, K., Mayer, E. A., & Labus, J. S. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.07.053 · Cited by 412
Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis
Ford, A. C., Quigley, E. M. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Moayyedi, P. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.148 · Cited by 405 · cited 2×
“67 and NNT of 4.(186) The quality of the data appeared to be better for tricyclic antidepressant (TCA) than selective serotonin reuptake inhibitor”
Background
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
Ruepert, L., Quartero, A. O., de Wit, N. J., van der Heijden, G. J., Rubin, G., & Muris, J. W. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003460.pub3 · Cited by 389
Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis
Wang, L.-H., Fang, X.-C., & Pan, G.-Z. (2004) · Gut · doi:10.1136/gut.2003.021154 · Cited by 387 · cited 1×
“8% among controls.(75) In a study from Seoul investigating an outbreak of Shigella infection among 181 health-care”
BackgroundSelf-citation
The Intestinal Microenvironment and Functional Gastrointestinal Disorders
Barbara, G., Feinle-Bisset, C., Ghoshal, U. C., Santos, J., Vanner, S. J., Vergnolle, N., Zoetendal, E. G., & Quigley, E. M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.028 · Cited by 335
Self-citation
Evidence that independent gut‐to‐brain and brain‐to‐gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1‐year population‐based prospective study
Koloski, N. A., Jones, M., & Talley, N. J. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13738 · Cited by 318
Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
Lembo, A., Pimentel, M., Rao, S. S., Schoenfeld, P., Cash, B., Weinstock, L. B., Paterson, C., Bortey, E., & Forbes, W. P. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.08.003 · Cited by 310
Linaclotide Inhibits Colonic Nociceptors and Relieves Abdominal Pain via Guanylate Cyclase-C and Extracellular Cyclic Guanosine 3′,5′-Monophosphate
Castro, J., Harrington, A. M., Hughes, P. A., Martin, C. M., Ge, P., Shea, C. M., Jin, H., Jacobson, S., Hannig, G., Mann, E., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.017 · Cited by 295
Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome
Sagami, Y., Shimada, Y., Tayama, J., Nomura, T., Satake, M., Endo, Y., Shoji, T., Karahashi, K., Hongo, M., & Fukudo, S. (2004) · Gut · doi:10.1136/gut.2003.018911 · Cited by 291
Self-citation
The Efficacy and Safety of Rifaximin for the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
Menees, S. B., Maneerattannaporn, M., Kim, H. M., & Chey, W. D. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.355 · Cited by 283 · cited 1×
“involving 5 high quality studies, found efficacy for global IBS symptoms, with secondary outcome analysis indicating that bloating could be the key symptom responding to rifaximin in nonconstipated IBS.(206) Adverse effects were similar among patients receiving rifaximin or placebo in all studies.”
Linaclotide Improves Abdominal Pain and Bowel Habits in a Phase IIb Study of Patients With Irritable Bowel Syndrome With Constipation
Johnston, J. M., Kurtz, C. B., MacDougall, J. E., Lavins, B. J., Currie, M. G., Fitch, D. A., O'Dea, C., Baird, M., & Lembo, A. J. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.041 · Cited by 229
Intestinal Serotonin Release, Sensory Neuron Activation, and Abdominal Pain in Irritable Bowel Syndrome
Cremon, C., Carini, G., Wang, B., Vasina, V., Cogliandro, R. F., De Giorgio, R., Stanghellini, V., Grundy, D., Tonini, M., De Ponti, F., et al. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.86 · Cited by 223
Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood: Meta-analysis: Lactobacillus GG and abdominal pain-related functional disorders
Horvath, A., Dziechciarz, P., & Szajewska, H. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04665.x · Cited by 201 · cited 1×
“While Lactobacillus rhamnosus GG has strong evidence in children, this was lacking in adult IBS patients.(181,182) In a study of adult IBS patients, Bifidobacterium infantis was found to improve symptoms over placebo, whereas Lactobacillus salivarius did not.”
Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome
Shin, A., Camilleri, M., Vijayvargiya, P., Busciglio, I., Burton, D., Ryks, M., Rhoten, D., Lueke, A., Saenger, A., Girtman, A., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.04.020 · Cited by 192
The Prevalence, Symptom Characteristics, and Impact of Irritable Bowel Syndrome in an Asian Urban Community
Gwee, K.-A., Wee, S., Wong, M.-L., & J C Png, D. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04161.x · Cited by 190
Self-citation
Psychological treatments for the management of irritable bowel syndrome
Zijdenbos, I. L., de Wit, N. J., van der Heijden, G. J., Rubin, G., & Quartero, A. O. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006442.pub2 · Cited by 180
Prevalence and Risk Factors for Overlaps between Gastroesophageal Reflux Disease, Dyspepsia, and Irritable Bowel Syndrome: A Population-Based Study
Lee, S. Y., Lee, K. J., Kim, S. J., & Cho, S. W. (2009) · Digestion · doi:10.1159/000211715 · Cited by 177
The Yield of Colonoscopy in Patients With Non-Constipated Irritable Bowel Syndrome: Results From a Prospective, Controlled US Trial
Chey, W. D., Nojkov, B., Rubenstein, J. H., Dobhan, R. R., Greenson, J. K., & Cash, B. D. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.55 · Cited by 175
The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria
WANG, A., LIAO, X., XIONG, L., PENG, S., XIAO, Y., LIU, S., HU, P., & CHEN, M. (2008) · BMC Gastroenterology · doi:10.1186/1471-230x-8-43 · Cited by 143
Self-citation
Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia
Tan, V. P. Y., Liu, K. S. H., Lam, F. Y. F., Hung, I. F. N., Yuen, M. F., & Leung, W. K. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13945 · Cited by 143
Short-term and long-term efficacy of psychological therapies for irritable bowel syndrome: a systematic review and meta-analysis
Laird, K. T., Tanner-Smith, E. E., Russell, A. C., Hollon, S. D., & Walker, L. S. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.11.020 · Cited by 135
Alosetron, a 5‐HT 3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers
Houghton, Foster, & Whorwell (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00762.x · Cited by 132
Efficacy and tolerability of guanylate cyclase-C agonists for irritable bowel syndrome with constipation and chronic idiopathic constipation: A systematic review and meta-analysis
Shah, E. D., Kim, H. M., & Schoenfeld, P. (2018) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.495 · Cited by 119
Altered cognitive function of prefrontal cortex during error feedback in patients with irritable bowel syndrome, based on FMRI and dynamic causal modeling
Aizawa, E., Sato, Y., Kochiyama, T., Saito, N., Izumiyama, M., Morishita, J., Kanazawa, M., Shima, K., Mushiake, H., Hongo, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.104 · Cited by 116
Self-citation
Prucalopride in the treatment of chronic constipation in patients from the Asia-pacific region: A randomized, double-blind, placebo-controlled study
Ke, M., Zou, D., Yuan, Y., Li, Y., Lin, L., Hao, J., Hou, X., & Kim, H. J. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01983.x · Cited by 107 · cited 1×
“Studies involving tegaserod and prucalopride, including 3 involving Asian subjects, provide evidence of efficacy in male subjects.(173,178,179)”
BackgroundSelf-citation
A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation
Yiannakou, Y., Piessevaux, H., Bouchoucha, M., Schiefke, I., Filip, R., Gabalec, L., Dina, I., Stephenson, D., Kerstens, R., Etherson, K., et al. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.115 · Cited by 104
Effect of autogenic training on general improvement in patients with irritable bowel syndrome: a randomized controlled trial
Shinozaki, M., Kanazawa, M., Kano, M., Endo, Y., Nakaya, N., Hongo, M., & Fukudo, S. (2010) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-009-9125-y · Cited by 67
Self-citation
The effects of cognitive behavioral therapy in female nursing students with irritable bowel syndrome: a randomized trial
Jang, A. L., Hwang, S.-K., & Kim, D. U. (2014) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000140 · Cited by 25

Research works printed but not linked: 185

10.1111/j.1440-1746.2010.06353.x · DOI
10.3310/hta2030 · DOI · Paper page
10.1136/bmj.328.7454.1490 · DOI · Paper page
10.1136/bmj.2.6138.653 · DOI · Paper page
10.1136/gut.25.10.1089 · DOI
10.1053/j.gastro.2016.02.031 · DOI · Paper page
10.1053/j.gastro.2013.04.049 · DOI
10.1111/jgh.13642 · DOI
10.1186/s13030-016-0070-8 · DOI
10.3748/wjg.v23.i37.6788 · DOI
10.1007/s12664-013-0365-7 · DOI
10.2478/rjim-2018-0017 · DOI
Fang X, Lu S, Pan G. [An epidemiologic study of bowel habit in adult non-patient population in Beijing area]. Zhonghua Yi Xue Za Zhi 2001;81:1287-1290 [Chinese].
10.1007/s10620-006-9509-2 · DOI
Ghoshal UC, Abraham P, Bhatt C, et al. Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian society of gastroenterology task fForce. Indian J Gastroenterol 2008;27:22-28.
10.1136/gut.39.1.109 · DOI
10.1097/00004836-199407000-00008 · DOI
10.1038/ajg.2009.612 · DOI
10.1016/j.purol.2014.06.008 · DOI
10.1136/gut.29.9.1236 · DOI
10.1056/NEJM197804202981604 · DOI · Paper page
10.1053/gast.1996.v110.pm8566585 · DOI
10.1111/j.1572-0241.2001.05336.x · DOI
10.1097/00042737-199805000-00011 · DOI
10.1111/j.1440-1746.2009.05984.x · DOI
10.1136/gutjnl-2016-312852 · DOI
10.1080/00365520510012190 · DOI
10.1046/j.1365-2036.2003.01711.x · DOI
10.1111/nmo.12510 · DOI
10.1038/ajg.2012.131 · DOI
10.1016/j.dld.2006.05.009 · DOI
10.5056/jnm.2011.17.1.82 · DOI
10.3748/wjg.v18.i44.6475 · DOI
10.2169/internalmedicine.54.5378 · DOI
10.1111/j.1572-0241.2001.03760.x · DOI
10.1186/1756-0500-5-255 · DOI
Shah SS, Bhatia SJ, Mistry FP. Epidemiology of dyspepsia in the general population in Mumbai. Indian J Gastroenterol 2001;20:103-106.
10.3748/wjg.v10.i7.1059 · DOI · Paper page
10.1136/gut.33.6.743 · DOI
10.1111/jgh.13465 · DOI
10.1007/s12664-014-0447-1 · DOI
10.1620/tjem.151.373 · DOI
10.1038/nrdp.2016.14 · DOI
10.3748/wjg.v20.i39.14126 · DOI · Paper page
10.1111/cns.12490 · DOI · Paper page
10.1053/j.gastro.2009.02.074 · DOI · Paper page
10.1136/gut.2007.119446 · DOI · Paper page
10.1136/gutjnl-2011-300474 · DOI · Paper page
10.1007/s10620-015-3607-y · DOI
10.1111/jgh.13471 · DOI
10.3109/00365521.2015.1116107 · DOI
10.1097/MEG.0000000000000122 · DOI · Paper page
10.1097/MEG.0000000000000557 · DOI
10.3748/wjg.v20.i10.2482 · DOI
10.1007/s12664-018-0901-6 · DOI
10.1007/s12664-018-0912-3 · DOI
10.1111/j.1572-0241.2006.00672.x · DOI · Paper page
10.1038/nrgastro.2010.4 · DOI · Paper page
10.1111/nmo.12399 · DOI
10.5056/jnm18130 · DOI
10.1155/2016/3230859 · DOI
10.1111/apt.13848 · DOI
10.1093/oxfordjournals.qjmed.a066971 · DOI · Paper page
10.1016/S0140-6736(96)90341-4 · DOI
10.1111/j.1440-1746.2005.03574.x · DOI
Kim HS, Kim MS, Ji SW, Park H. [The development of irritable bowel syndrome after Shigella infection: 3 year follow-up study]. Korean J Gastroenterol 2006;47:300-305 [Korean].
10.1038/s41395-018-0208-3 · DOI
10.1038/nrgastro.2017.37 · DOI
10.1053/j.gastro.2018.07.011 · DOI
10.1016/0016-5085(95)90267-8 · DOI · Paper page
10.1111/j.1440-1746.2007.04986.x · DOI
10.1007/BF02212678 · DOI
10.1038/ajg.2013.198 · DOI
10.1007/s00535-005-1766-x · DOI
10.1097/00004836-199401000-00006 · DOI
10.1186/1471-230X-14-23 · DOI
10.1016/S1542-3565(04)00726-8 · DOI
10.1111/j.1365-2036.2007.03396.x · DOI
10.1080/00365521.2017.1305123 · DOI
Jeong JB, Yang YM, Jeon WJ, et al. Postprandial colonic motor activity in patients with irritable bowel syndrome. Kor J Neurogastroenterol Motil 2000;6:20-30.
Shah SK, Abraham P, Mistry FP. Effect of cold pressor test and a high-chilli diet on rectosigmoid motility in irritable bowel syndrome. Indian J Gastroenterol 2000;19:161-164.
10.1111/j.1365-2982.2008.01167.x · DOI
10.1007/s00535-006-1942-7 · DOI
10.1016/j.cgh.2008.02.060 · DOI
Tandon RK, Prasad N, Gupta MC, Tandon BN. Stool weights and transit time in North Indians. J Assoc Physicians India 1976;24:807-810.
10.1111/j.1440-1746.2004.03492.x · DOI
10.1111/j.1365-2982.2004.00498.x · DOI
10.3748/wjg.v9.i6.1356 · DOI
10.1016/j.pain.2006.06.017 · DOI
10.5056/jnm16148 · DOI
10.1159/000269822 · DOI
Cho KR, Lee OY, Yoon DH, et al. The influence of depression on gastrointestinal symptoms in women. Kor J Neurogastroenterol Motil 2007;13:146-151.
10.1097/MCG.0b013e318150d006 · DOI
10.1046/j.1365-2036.2002.01377.x · DOI
10.1111/j.1365-2982.2008.01143.x · DOI
10.1023/B:DDAS.0000034570.52305.10 · DOI
Jun DW, Lee OY, Jo GL, et al. The comparison of irritable bowel syndrome between consulters and non-consulters. Kor J Neurogastroenterol Motil 2018;11:50-57.
10.5056/jnm14071 · DOI
10.5056/jnm17020 · DOI
10.5056/jnm17022 · DOI
10.3109/00365521.2012.758767 · DOI
10.1053/j.gastro.2013.08.048 · DOI
10.3109/00365521.2015.1007079 · DOI
10.1136/flgastro-2015-100651 · DOI
10.1016/j.ogc.2016.01.006 · DOI
10.17235/reed.2016.4352/2016 · DOI
Corsetti M, Whorwell PJ. Managing irritable bowel syndrome in primary care. Practitioner 2015;259:2124, 2-3.
10.1038/ajg.2015.6 · DOI · Paper page
Vasquez-Rios G, Machicado JD, Terashima A, Marcos LA. Irritable bowel syndrome and intestinal parasites: a view from South America. Rev Gastroenterol Peru 2016;36:153-158.
10.1136/gutjnl-2013-306503 · DOI · Paper page
10.1111/1751-2980.12260 · DOI
Chowdhury MK, Chakraborty R, Gope S, et al. Celiac disease in patients fulfilling the Rome III criteria for irritable bowel syndrome attending gastroenterology department of a tertiary care hospital in bangladesh. Mymensingh Med J 2016;25:102-108.
10.1097/MD.0000000000001779 · DOI
10.1007/s12664-016-0631-6 · DOI
10.1097/MCG.0b013e31820c6001 · DOI
10.1007/s12664-017-0757-1 · DOI
10.5056/jnm.2014.20.2.236 · DOI
10.3390/nu7064542 · DOI
10.3390/nu7125541 · DOI
10.5056/jnm.2011.17.3.245 · DOI
10.1186/1471-230X-12-104 · DOI
10.1007/s11136-009-9461-7 · DOI
10.1111/jgh.13987 · DOI
10.1111/j.1440-1746.2010.06370.x · DOI · Paper page
10.1053/j.gastro.2013.09.046 · DOI · Paper page
10.5056/jnm15111 · DOI
10.1111/jgh.13885 · DOI
10.1016/j.cgh.2012.11.034 · DOI
10.1111/jgh.12273 · DOI
10.1136/bmj.a2313 · DOI · Paper page
10.1016/j.cgh.2015.01.015 · DOI
10.1046/j.1440-1746.2000.02230.x · DOI
10.5056/jnm.2011.17.4.402 · DOI
10.1007/BF02936952 · DOI · Paper page
10.1007/BF01296258 · DOI
10.3109/00365528709091003 · DOI
10.3109/00365529609006766 · DOI
10.1111/j.1440-1746.2007.04895.x · DOI
10.1111/j.1365-2036.2005.02330.x · DOI
10.1111/j.1365-2036.2004.02180.x · DOI
10.1159/000201377 · DOI
10.1159/000150632 · DOI
10.1080/00365520802240255 · DOI
10.1053/j.gastro.2015.10.047 · DOI · Paper page
10.1038/ajg.2014.187 · DOI
10.1136/gutjnl-2013-305989 · DOI · Paper page
10.1136/gut.52.5.671 · DOI
10.1111/j.1572-0241.2006.00988.x · DOI
10.1111/j.1440-1746.2006.04543.x · DOI
10.1111/j.1365-2036.2012.05011.x · DOI · Paper page
10.1007/s10151-013-1017-8 · DOI
10.1111/nmo.12217 · DOI
10.5009/gnl14290 · DOI
10.3748/wjg.v20.i43.16215 · DOI
10.1111/j.1572-0241.2006.00734.x · DOI · Paper page
10.1111/jgh.14268 · DOI
10.1111/j.1365-2036.2008.03633.x · DOI
Ghadir MR, Habibinejad H, Heidari A, Vahedi H. Doxepin is more effective than nortriptyline and placebo for the treatment of diarrhea-predominant irritable bowel syndrome: a randomized triple-blind placebo-controlled trial. Tehran Univ Med J 2011;69:352-358.
Nigam P, Kapoor KK, Rastog CK, Kumar A, Gupta AK. Different therapeutic regimens in irritable bowel syndrome. J Assoc Physicians India 1984;32:1041-1044.
10.1016/j.cgh.2009.09.008 · DOI
10.1007/s10620-007-9830-4 · DOI
10.1053/j.gastro.2007.06.067 · DOI
10.1111/jgh.14086 · DOI
10.1038/ajg.2012.255 · DOI
10.1038/ajg.2012.254 · DOI · Paper page
10.1111/apt.12123 · DOI
Crowell MD, Harris LA, DiBaise JK, Olden KW. Activation of type-2 chloride channels: a novel therapeutic target for the treatment of chronic constipation. Curr Opin Investig Drugs 2007;8:66-70.
10.1111/j.1365-2982.2011.01668.x · DOI
10.1111/j.1365-2036.2008.03629.x · DOI
10.1016/j.clinthera.2006.12.013 · DOI
10.1111/j.1365-2036.2011.04983.x · DOI
10.1016/j.mayocp.2016.01.015 · DOI
10.1111/apt.12735 · DOI · Paper page
10.1007/s10620-017-4598-7 · DOI
10.1111/nmo.12331 · DOI
10.1111/j.1365-2982.2009.01290.x · DOI
10.1038/ajg.2009.156 · DOI
10.1136/gut.2005.074518 · DOI
10.1155/2016/4071260 · DOI
10.1371/journal.pone.0122397 · DOI
10.1371/journal.pone.0192319 · DOI
10.1016/j.cgh.2017.06.026 · DOI
10.1136/gutjnl-2016-312852 · DOI
10.1136/gutjnl-2017-314775 · DOI
10.1016/j.cgh.2018.02.042 · DOI

Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis
Zhang, T., Zhang, C., Zhang, J., Sun, F., & Duan, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.859967 · Cited by 125
Global prevalence and risk factors of irritable bowel syndrome from 2006 to 2024 using the Rome III and IV criteria: a meta-analysis
Arif, T. B., Ali, S. H., Bhojwani, K. D., Sadiq, M., Siddiqui, A. A., Ur-Rahman, A., Khan, M. Z., Hasan, F., & Shahzil, M. (2025) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002994 · Cited by 50
Prevalence of irritable bowel syndrome in Japan, China, and South Korea: an international cross-sectional study
Takeoka, A., Kimura, T., Hara, S., Hamaguchi, T., Fukudo, S., & Tayama, J. (2023) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm22037 · Cited by 30
Self-citation
Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines
Pastras, P., Aggeletopoulou, I., Bali, M., & Triantos, C. (2026) · Nutrients · doi:10.3390/nu18020183 · Cited by 1

See all 112

Authors: Gwee, K. A., Gonlachanvit, S., Ghoshal, U. C., Chua, A. S. B., Miwa, H., Wu, J., Bak, Y.-T., Lee, O. Y., Lu, C.-L., Park, H., Chen, M., Syam, A. F., Abraham, P., Sollano, J., Chang, C.-S., Suzuki, H., Fang, X., Fukudo, S., Choi, M.-G., Hou, X., & Hongo, M.
Affiliations: Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, and Gleneagles Hospital, Singapore
Center of Excellence on Neurogastroenterology and Motility, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
Gastro Centre, Ipoh, Malaysia
5 Division of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine, Mukogawa-cho, Nishinomiya, Hyogo, Japan
Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, New Territories, Hong Kong
Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
Department of Gastroenterology, College of Medicine, Hanyang University, Seoul, Korea
Endoscopy Center for Diagnosis and Treatment, Taipei Veterans General Hospital, Taipei, Taiwan
Division of Gastroenterology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Division of Gastroenterology, Departement of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
Division of Gastroenterology, P D Hinduja Hospital, Mumbai, India
Department of Internal Medicine, Division of Gastroenterology, University of Santo Tomas, Manila, Philippine
Taichung Veterans General Hospital, Taiwan Boulevard, Taichung City, Taiwan
Department of Gastroenterology and Hepatology, Tokai University School of Medicine, Isehara, Kanagawa, Japan
Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Colleg e, Beijing, China
Department of Behavioral Medicine, Tohoku University Graduate School of Medicine, Aoba Sendai, Japan
Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Department of Medicine, Kurokawa General Hospital, Kurokawa, Miyagi, Japan
Venue: Journal of Neurogastroenterology and Motility
Publisher: The Korean Society of Neurogastroenterology and Motility
Published: 2019-07-01
Volume: 25
Issue: 3
Pages: 343-362
ISSN: 2093-0879
2093-0887
DOI: 10.5056/jnm19041
Cited by: 112
References: 42
Language: en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Second Asian Consensus on Irritable Bowel Syndrome

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources